The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices - PubMed (original) (raw)
The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices
Mark Anthony Laudadio et al. Epilepsy Res. 2004 Apr-May.
Abstract
The effects of the A(3) adenosine receptor agonist 2-Cl-IB-MECA were tested on epileptiform field potentials recorded in the CA3 area of postnatal days 10-20 immature hippocampal slices, during perfusion with the GABA(A) receptor antagonist bicuculline (10 microM). Evoked potentials: 2-Cl-IB-MECA (1-50 microM, n = 17) had consistently excitatory effects, blocked by the A(3) receptor antagonist MRS 1220 (1 microM, n = 7), but not occluded in the presence of the A(1) antagonist DPCPX (1 microM, n = 12) or the A(2A) antagonist ZM-241385 (0.1 microM, n = 12). 2-Cl-IB-MECA reversed the inhibitory effects (n = 5) of the adenosine uptake blocker nitrobenzylthioinosine (NBTI, 50 microM), but did not increase its excitatory effects (n = 19). Spontaneous discharges: 2-Cl-IB-MECA (1 microM) induced them or increased their frequency in 14/30 slices, an effect reversed by MRS 1220 (n = 3), and observed also following pre-perfusion with DPCPX (n = 11), ZM-241385 (n = 11) or both (n = 10). In the presence of the A(1) antagonist DPCPX, NBTI increased the frequency of spontaneous discharges, an effect partially reversed by MRS 1220 (n = 8), thus suggesting that a rise in endogenous adenosine during disinhibition may activate A(3) receptors. In conclusion, these findings suggest strongly that activation of A(3) receptors, following a rise in endogenous adenosine (i.e. during seizures, hypoxia), facilitates excitation, thus limiting the known inhibitory and/or neuroprotective effects of adenosine in immature brain.
Similar articles
- Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.
Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA. Dunwiddie TV, et al. J Neurosci. 1997 Jan 15;17(2):607-14. doi: 10.1523/JNEUROSCI.17-02-00607.1997. J Neurosci. 1997. PMID: 8987783 Free PMC article. - P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
Mlejnek P, Dolezel P, Kosztyu P. Mlejnek P, et al. J Cell Physiol. 2012 Feb;227(2):676-85. doi: 10.1002/jcp.22775. J Cell Physiol. 2012. PMID: 21520073 - Nicotinic effects on excitatory field potentials recorded from the immature CA3 area of rat hippocampal slices.
Psarropoulou C, Boivin M, Laudadio MA. Psarropoulou C, et al. Exp Brain Res. 2003 Oct;152(3):353-60. doi: 10.1007/s00221-003-1546-x. Epub 2003 Jul 26. Exp Brain Res. 2003. PMID: 12898092 - Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.
Shneyvays V, Nawrath H, Jacobson KA, Shainberg A. Shneyvays V, et al. Exp Cell Res. 1998 Sep 15;243(2):383-97. doi: 10.1006/excr.1998.4134. Exp Cell Res. 1998. PMID: 9743598 - Adenosine receptors as potential targets in melanoma.
Montinaro A, Iannone R, Pinto A, Morello S. Montinaro A, et al. Pharmacol Res. 2013 Oct;76:34-40. doi: 10.1016/j.phrs.2013.07.002. Epub 2013 Jul 13. Pharmacol Res. 2013. PMID: 23856527 Review.
Cited by
- Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System.
Coppi E, Cherchi F, Venturini M, Lucarini E, Corradetti R, Di Cesare Mannelli L, Ghelardini C, Pedata F, Pugliese AM. Coppi E, et al. Molecules. 2022 Mar 15;27(6):1890. doi: 10.3390/molecules27061890. Molecules. 2022. PMID: 35335254 Free PMC article. Review. - Role of Adenosine in Epilepsy and Seizures.
Tescarollo FC, Rombo DM, DeLiberto LK, Fedele DE, Alharfoush E, Tomé ÂR, Cunha RA, Sebastião AM, Boison D. Tescarollo FC, et al. J Caffeine Adenosine Res. 2020 Jun 1;10(2):45-60. doi: 10.1089/caff.2019.0022. Epub 2020 Jun 4. J Caffeine Adenosine Res. 2020. PMID: 32566903 Free PMC article. Review. - The role of ATP and adenosine in the brain under normoxic and ischemic conditions.
Pedata F, Melani A, Pugliese AM, Coppi E, Cipriani S, Traini C. Pedata F, et al. Purinergic Signal. 2007 Sep;3(4):299-310. doi: 10.1007/s11302-007-9085-8. Epub 2007 Oct 11. Purinergic Signal. 2007. PMID: 18404443 Free PMC article. - 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.
Kotulova J, Lonova K, Kubickova A, Vrbkova J, Kourilova P, Hajduch M, Dzubak P. Kotulova J, et al. Int J Mol Med. 2022 Mar;49(3):31. doi: 10.3892/ijmm.2022.5086. Epub 2022 Jan 18. Int J Mol Med. 2022. PMID: 35039871 Free PMC article. - Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
Effendi WI, Nagano T, Kobayashi K, Nishimura Y. Effendi WI, et al. Cells. 2020 Mar 24;9(3):785. doi: 10.3390/cells9030785. Cells. 2020. PMID: 32213945 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous